Chronic Kidney Disease Clinical Trials in Washington D.C., District of Columbia
7 recruitingWashington D.C., District of Columbia
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuriaChildren
Bayer100 enrolled178 locationsNCT05457283
Recruiting
Not Applicable
Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease
Chronic Kidney Disease Predialysis
VA Office of Research and Development30 enrolled1 locationNCT04397159
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Phase 1Phase 2
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
Chronic Kidney Disease(CKD)
Regeneron Pharmaceuticals56 enrolled10 locationsNCT05092347
Recruiting
Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuria
Bayer219 enrolled154 locationsNCT05196035
Recruiting
Not Applicable
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
HypertensionChronic Kidney DiseasesDiabetes+1 more
Johns Hopkins University425 enrolled3 locationsNCT05321368
Recruiting
Phase 4
Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
Chronic Kidney Diseases
Washington D.C. Veterans Affairs Medical Center60 enrolled1 locationNCT06110130